Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression
Identifieur interne : 001154 ( Istex/Corpus ); précédent : 001153; suivant : 001155Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression
Auteurs : Katrina J. Light ; Peter R. Joyce ; Suzanne E. Luty ; Roger T. Mulder ; Christropher M. A. Frampton ; Laura R. M. Joyce ; Allison L. Miller ; Martin A. KennedySource :
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics [ 1552-4841 ] ; 2006-06-05.
English descriptors
- Teeft :
- Allele, Allele frequencies, Andrea bartram, Anxiety disorder diagnoses, Blood sample, Character inventory, Christchurch, Christchurch school, Clinical interview, Clinical psychologist, Clinical sample, Compulsive personality disorder, Conditional independence, Consistent association, Consistent trend, Depressed individuals, Depressed patients, Disorder, Dopamine, Dopamine receptors, Dopamine release, Drd3, Drd3 agonists, Drd3 genotype, Drd3 polymorphism, Drd3 polymorphisms, Epidemiological survey, Exact test, Family study, Gender, Genet part, Genotype, Independent samples, Knockout mice, Locomotor activity, Locomotor inhibition, Major depression, Male gender, Medicine health sciences, Motor control, Neural transm, Neuropsychiatric interview, Obsessivecompulsive disorder, Ocpd, Ocpd diagnosis, Ocpd symptoms, Original sample, Original study, Overall association, Panic disorder, Personality disorder, Personality disorders, Personality trait, Personality traits, Polymorphism, Potential predictors, Predictor, Preliminary evidence, Psychiatric disorders, Psychological medicine, Receptor, Receptor gene variant, Recurrent depression, Replication, Replication sample, Replication samples, Risk factor, Second replication sample, Temperament traits.
Abstract
We have previously reported that the Ser9Gly dopamine D3 receptor (DRD3) polymorphism was associated with increased rates of obsessive‐compulsive personality disorder (OCPD) symptomology. We tested the replicability of this association within a further two independent groups of individuals with a history of depression, from a clinical sample (n = 149) and a family study (n = 213). The data from the replication samples and the original sample, within which the association was found, were compiled within a meta‐analysis. Although the independent samples did not replicate the original finding, the meta‐analysis elucidated significant evidence supporting the association. An individual with Gly/Gly genotype is 2.4 (P = 0.017) times more likely to be diagnosed with OCPD. Male gender was also found to be a significant predictor of OCPD diagnosis (OR = 2.82, P = 0.001). An exploration of an association of DRD3 with Axis I anxiety disorder diagnoses and Temperament and Character Inventory (TCI) traits, in particular persistence, revealed no support for an association. We conclude that DRD3 may contribute to the development of OCPD. © 2006 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/ajmg.b.30308
Links to Exploration step
ISTEX:A4F78EDBF3F904AB205F89D64F4B27BA47774FE7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression</title><author><name sortKey="Light, Katrina J" sort="Light, Katrina J" uniqKey="Light K" first="Katrina J." last="Light">Katrina J. Light</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: katrina.light@chmeds.ac.nz</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence address: Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, PO Box 4345, Christchurch, New Zealand.</mods:affiliation></affiliation></author><author><name sortKey="Joyce, Peter R" sort="Joyce, Peter R" uniqKey="Joyce P" first="Peter R." last="Joyce">Peter R. Joyce</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Luty, Suzanne E" sort="Luty, Suzanne E" uniqKey="Luty S" first="Suzanne E." last="Luty">Suzanne E. Luty</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Mulder, Roger T" sort="Mulder, Roger T" uniqKey="Mulder R" first="Roger T." last="Mulder">Roger T. Mulder</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Frampton, Christropher M A" sort="Frampton, Christropher M A" uniqKey="Frampton C" first="Christropher M. A." last="Frampton">Christropher M. A. Frampton</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Joyce, Laura R M" sort="Joyce, Laura R M" uniqKey="Joyce L" first="Laura R. M." last="Joyce">Laura R. M. Joyce</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Miller, Allison L" sort="Miller, Allison L" uniqKey="Miller A" first="Allison L." last="Miller">Allison L. Miller</name><affiliation><mods:affiliation>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Kennedy, Martin A" sort="Kennedy, Martin A" uniqKey="Kennedy M" first="Martin A." last="Kennedy">Martin A. Kennedy</name><affiliation><mods:affiliation>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A4F78EDBF3F904AB205F89D64F4B27BA47774FE7</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/ajmg.b.30308</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-L96SPX26-3/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001154</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001154</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression</title><author><name sortKey="Light, Katrina J" sort="Light, Katrina J" uniqKey="Light K" first="Katrina J." last="Light">Katrina J. Light</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: katrina.light@chmeds.ac.nz</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence address: Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, PO Box 4345, Christchurch, New Zealand.</mods:affiliation></affiliation></author><author><name sortKey="Joyce, Peter R" sort="Joyce, Peter R" uniqKey="Joyce P" first="Peter R." last="Joyce">Peter R. Joyce</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Luty, Suzanne E" sort="Luty, Suzanne E" uniqKey="Luty S" first="Suzanne E." last="Luty">Suzanne E. Luty</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Mulder, Roger T" sort="Mulder, Roger T" uniqKey="Mulder R" first="Roger T." last="Mulder">Roger T. Mulder</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Frampton, Christropher M A" sort="Frampton, Christropher M A" uniqKey="Frampton C" first="Christropher M. A." last="Frampton">Christropher M. A. Frampton</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Joyce, Laura R M" sort="Joyce, Laura R M" uniqKey="Joyce L" first="Laura R. M." last="Joyce">Laura R. M. Joyce</name><affiliation><mods:affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Miller, Allison L" sort="Miller, Allison L" uniqKey="Miller A" first="Allison L." last="Miller">Allison L. Miller</name><affiliation><mods:affiliation>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author><author><name sortKey="Kennedy, Martin A" sort="Kennedy, Martin A" uniqKey="Kennedy M" first="Martin A." last="Kennedy">Martin A. Kennedy</name><affiliation><mods:affiliation>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</title><title level="j" type="alt">AMERICAN JOURNAL OF MEDICAL GENETICS PART B: NEUROPSYCHIATRIC GENETICS</title><idno type="ISSN">1552-4841</idno><idno type="eISSN">1552-485X</idno><imprint><biblScope unit="vol">141B</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="409">409</biblScope><biblScope unit="page" to="413">413</biblScope><biblScope unit="page-count">5</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-06-05">2006-06-05</date></imprint><idno type="ISSN">1552-4841</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1552-4841</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Allele</term><term>Allele frequencies</term><term>Andrea bartram</term><term>Anxiety disorder diagnoses</term><term>Blood sample</term><term>Character inventory</term><term>Christchurch</term><term>Christchurch school</term><term>Clinical interview</term><term>Clinical psychologist</term><term>Clinical sample</term><term>Compulsive personality disorder</term><term>Conditional independence</term><term>Consistent association</term><term>Consistent trend</term><term>Depressed individuals</term><term>Depressed patients</term><term>Disorder</term><term>Dopamine</term><term>Dopamine receptors</term><term>Dopamine release</term><term>Drd3</term><term>Drd3 agonists</term><term>Drd3 genotype</term><term>Drd3 polymorphism</term><term>Drd3 polymorphisms</term><term>Epidemiological survey</term><term>Exact test</term><term>Family study</term><term>Gender</term><term>Genet part</term><term>Genotype</term><term>Independent samples</term><term>Knockout mice</term><term>Locomotor activity</term><term>Locomotor inhibition</term><term>Major depression</term><term>Male gender</term><term>Medicine health sciences</term><term>Motor control</term><term>Neural transm</term><term>Neuropsychiatric interview</term><term>Obsessivecompulsive disorder</term><term>Ocpd</term><term>Ocpd diagnosis</term><term>Ocpd symptoms</term><term>Original sample</term><term>Original study</term><term>Overall association</term><term>Panic disorder</term><term>Personality disorder</term><term>Personality disorders</term><term>Personality trait</term><term>Personality traits</term><term>Polymorphism</term><term>Potential predictors</term><term>Predictor</term><term>Preliminary evidence</term><term>Psychiatric disorders</term><term>Psychological medicine</term><term>Receptor</term><term>Receptor gene variant</term><term>Recurrent depression</term><term>Replication</term><term>Replication sample</term><term>Replication samples</term><term>Risk factor</term><term>Second replication sample</term><term>Temperament traits</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We have previously reported that the Ser9Gly dopamine D3 receptor (DRD3) polymorphism was associated with increased rates of obsessive‐compulsive personality disorder (OCPD) symptomology. We tested the replicability of this association within a further two independent groups of individuals with a history of depression, from a clinical sample (n = 149) and a family study (n = 213). The data from the replication samples and the original sample, within which the association was found, were compiled within a meta‐analysis. Although the independent samples did not replicate the original finding, the meta‐analysis elucidated significant evidence supporting the association. An individual with Gly/Gly genotype is 2.4 (P = 0.017) times more likely to be diagnosed with OCPD. Male gender was also found to be a significant predictor of OCPD diagnosis (OR = 2.82, P = 0.001). An exploration of an association of DRD3 with Axis I anxiety disorder diagnoses and Temperament and Character Inventory (TCI) traits, in particular persistence, revealed no support for an association. We conclude that DRD3 may contribute to the development of OCPD. © 2006 Wiley‐Liss, Inc.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>ocpd</json:string><json:string>receptor</json:string><json:string>drd3</json:string><json:string>genotype</json:string><json:string>dopamine</json:string><json:string>polymorphism</json:string><json:string>predictor</json:string><json:string>replication</json:string><json:string>replication sample</json:string><json:string>ocpd diagnosis</json:string><json:string>personality disorder</json:string><json:string>christchurch</json:string><json:string>depressed individuals</json:string><json:string>replication samples</json:string><json:string>original sample</json:string><json:string>allele</json:string><json:string>clinical interview</json:string><json:string>personality disorders</json:string><json:string>male gender</json:string><json:string>family study</json:string><json:string>gender</json:string><json:string>neural transm</json:string><json:string>anxiety disorder diagnoses</json:string><json:string>major depression</json:string><json:string>clinical sample</json:string><json:string>medicine health sciences</json:string><json:string>christchurch school</json:string><json:string>independent samples</json:string><json:string>dopamine receptors</json:string><json:string>personality traits</json:string><json:string>exact test</json:string><json:string>receptor gene variant</json:string><json:string>second replication sample</json:string><json:string>temperament traits</json:string><json:string>disorder</json:string><json:string>preliminary evidence</json:string><json:string>consistent trend</json:string><json:string>obsessivecompulsive disorder</json:string><json:string>panic disorder</json:string><json:string>genet part</json:string><json:string>consistent association</json:string><json:string>depressed patients</json:string><json:string>blood sample</json:string><json:string>clinical psychologist</json:string><json:string>recurrent depression</json:string><json:string>original study</json:string><json:string>neuropsychiatric interview</json:string><json:string>drd3 polymorphisms</json:string><json:string>knockout mice</json:string><json:string>conditional independence</json:string><json:string>potential predictors</json:string><json:string>ocpd symptoms</json:string><json:string>locomotor activity</json:string><json:string>personality trait</json:string><json:string>allele frequencies</json:string><json:string>drd3 polymorphism</json:string><json:string>overall association</json:string><json:string>drd3 genotype</json:string><json:string>drd3 agonists</json:string><json:string>locomotor inhibition</json:string><json:string>risk factor</json:string><json:string>motor control</json:string><json:string>epidemiological survey</json:string><json:string>compulsive personality disorder</json:string><json:string>psychiatric disorders</json:string><json:string>andrea bartram</json:string><json:string>psychological medicine</json:string><json:string>character inventory</json:string><json:string>dopamine release</json:string></teeft></keywords><author><json:item><name>Katrina J. Light</name><affiliations><json:string>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</json:string><json:string>E-mail: katrina.light@chmeds.ac.nz</json:string><json:string>Correspondence address: Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, PO Box 4345, Christchurch, New Zealand.</json:string></affiliations></json:item><json:item><name>Peter R. Joyce</name><affiliations><json:string>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</json:string></affiliations></json:item><json:item><name>Suzanne E. Luty</name><affiliations><json:string>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</json:string></affiliations></json:item><json:item><name>Roger T. Mulder</name><affiliations><json:string>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</json:string></affiliations></json:item><json:item><name>Christropher M.A. Frampton</name><affiliations><json:string>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</json:string></affiliations></json:item><json:item><name>Laura R.M. Joyce</name><affiliations><json:string>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</json:string></affiliations></json:item><json:item><name>Allison L. Miller</name><affiliations><json:string>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</json:string></affiliations></json:item><json:item><name>Martin A. Kennedy</name><affiliations><json:string>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>dopamine D3 receptor gene</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>obsessive‐compulsive personality disorder</value></json:item></subject><articleId><json:string>AJMG30308</json:string></articleId><arkIstex>ark:/67375/WNG-L96SPX26-3</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>We have previously reported that the Ser9Gly dopamine D3 receptor (DRD3) polymorphism was associated with increased rates of obsessive‐compulsive personality disorder (OCPD) symptomology. We tested the replicability of this association within a further two independent groups of individuals with a history of depression, from a clinical sample (n = 149) and a family study (n = 213). The data from the replication samples and the original sample, within which the association was found, were compiled within a meta‐analysis. Although the independent samples did not replicate the original finding, the meta‐analysis elucidated significant evidence supporting the association. An individual with Gly/Gly genotype is 2.4 (P = 0.017) times more likely to be diagnosed with OCPD. Male gender was also found to be a significant predictor of OCPD diagnosis (OR = 2.82, P = 0.001). An exploration of an association of DRD3 with Axis I anxiety disorder diagnoses and Temperament and Character Inventory (TCI) traits, in particular persistence, revealed no support for an association. We conclude that DRD3 may contribute to the development of OCPD. © 2006 Wiley‐Liss, Inc.</abstract><qualityIndicators><score>8.114</score><pdfWordCount>4110</pdfWordCount><pdfCharCount>26521</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>5</pdfPageCount><pdfPageSize>594 x 792 pts</pdfPageSize><pdfWordsPerPage>822</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>167</abstractWordCount><abstractCharCount>1164</abstractCharCount><keywordCount>2</keywordCount></qualityIndicators><title>Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression</title><pmid><json:string>16583407</json:string></pmid><genre><json:string>article</json:string></genre><host><title>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1552-485X</json:string></doi><issn><json:string>1552-4841</json:string></issn><eissn><json:string>1552-485X</json:string></eissn><publisherId><json:string>AJMG</json:string></publisherId><volume>141B</volume><issue>4</issue><pages><first>409</first><last>413</last><total>5</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Research Article</value></json:item><json:item><value>Research Articles</value></json:item></subject></host><namedEntities><unitex><date><json:string>2006</json:string></date><geogName></geogName><orgName><json:string>Laboratory Methodology As</json:string><json:string>Canterbury Ethics Committee, Christchurch, New Zealand</json:string><json:string>Department of Psychological Medicine, Christchurch School of Medicine</json:string><json:string>Wiley-Liss, Inc</json:string><json:string>New Zealand Department of Pathology, Christchurch School of Medicine</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Allison L. Miller</json:string><json:string>R.M. Joyce</json:string><json:string>Isobel Stevens</json:string><json:string>Elisabeth Wells</json:string><json:string>Roger T. Mulder</json:string><json:string>The</json:string><json:string>Robyn Abbott</json:string><json:string>To</json:string><json:string>Suzanne E. Luty</json:string><json:string>Sarah Rowe</json:string><json:string>Andrea Bartram</json:string><json:string>Martin A. Kennedy</json:string><json:string>M.A. Frampton</json:string></persName><placeName><json:string>Christchurch</json:string><json:string>Baltimore</json:string><json:string>MD</json:string><json:string>New Zealand</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Henderson et al., 2000</json:string><json:string>Waters et al., 1994</json:string><json:string>Samuels et al., 2000</json:string><json:string>Spitzer et al., 1987</json:string><json:string>Czermak et al. [2004]</json:string><json:string>Sokoloff et al., 1990</json:string><json:string>Xu et al., 1997</json:string><json:string>Svensson et al., 1994a,b</json:string><json:string>Villemarette-Pittman et al., 2004</json:string><json:string>Spitzer et al., 1992</json:string><json:string>Joyce et al., 2002</json:string><json:string>Wong et al., 2000</json:string><json:string>Nestadt et al., 1991</json:string><json:string>Suzuki et al., 1998</json:string><json:string>Jonsson et al., 2003</json:string><json:string>Caine and Koob, 1993</json:string><json:string>Larson and Ariano, 1995</json:string><json:string>Mulder and Joyce, 1997</json:string><json:string>Montgomery and Asberg, 1979</json:string><json:string>KlingPetersen et al., 1995</json:string><json:string>Cloninger et al., 1993</json:string><json:string>Villemarette-Pittman et al. [2004]</json:string><json:string>Accili et al., 1996</json:string><json:string>Ciulla et al. [1988]</json:string><json:string>[2005]</json:string><json:string>Light et al.</json:string><json:string>Lannfelt et al., 1992</json:string><json:string>Menalled et al., 1999</json:string><json:string>Daly and Waddington, 1993</json:string><json:string>Lundstrom and Turpin, 1996</json:string><json:string>Sheehan et al., 1998</json:string><json:string>Joyce et al. [2003]</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-L96SPX26-3</json:string></ark><categories><inist><json:string>1 - sciences humaines et sociales</json:string></inist></categories><publicationDate>2006</publicationDate><copyrightDate>2006</copyrightDate><doi><json:string>10.1002/ajmg.b.30308</json:string></doi><id>A4F78EDBF3F904AB205F89D64F4B27BA47774FE7</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-L96SPX26-3/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-L96SPX26-3/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-L96SPX26-3/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression</title><title level="a" type="short" xml:lang="en">Dopamine D3 Receptor and Obsessive‐Compulsive Personality Disorder</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><licence>Copyright © 2006 Wiley‐Liss, Inc.</licence></availability><date type="published" when="2006-06-05"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression</title><title level="a" type="short" xml:lang="en">Dopamine D3 Receptor and Obsessive‐Compulsive Personality Disorder</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">Katrina J.</forename><surname>Light</surname></persName><email>katrina.light@chmeds.ac.nz</email><affiliation><orgName type="division">Department of Psychological Medicine</orgName><orgName type="department">Christchurch School of Medicine & Health Sciences</orgName><address><addrLine>Christchurch</addrLine><addrLine>New Zealand</addrLine><country key="NZ" xml:lang="en">NEW ZEALAND</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Peter R.</forename><surname>Joyce</surname></persName><affiliation><orgName type="division">Department of Psychological Medicine</orgName><orgName type="department">Christchurch School of Medicine & Health Sciences</orgName><address><addrLine>Christchurch</addrLine><addrLine>New Zealand</addrLine><country key="NZ" xml:lang="en">NEW ZEALAND</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Suzanne E.</forename><surname>Luty</surname></persName><affiliation><orgName type="division">Department of Psychological Medicine</orgName><orgName type="department">Christchurch School of Medicine & Health Sciences</orgName><address><addrLine>Christchurch</addrLine><addrLine>New Zealand</addrLine><country key="NZ" xml:lang="en">NEW ZEALAND</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">Roger T.</forename><surname>Mulder</surname></persName><affiliation><orgName type="division">Department of Psychological Medicine</orgName><orgName type="department">Christchurch School of Medicine & Health Sciences</orgName><address><addrLine>Christchurch</addrLine><addrLine>New Zealand</addrLine><country key="NZ" xml:lang="en">NEW ZEALAND</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Christropher M.A.</forename><surname>Frampton</surname></persName><affiliation><orgName type="division">Department of Psychological Medicine</orgName><orgName type="department">Christchurch School of Medicine & Health Sciences</orgName><address><addrLine>Christchurch</addrLine><addrLine>New Zealand</addrLine><country key="NZ" xml:lang="en">NEW ZEALAND</country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">Laura R.M.</forename><surname>Joyce</surname></persName><affiliation><orgName type="division">Department of Psychological Medicine</orgName><orgName type="department">Christchurch School of Medicine & Health Sciences</orgName><address><addrLine>Christchurch</addrLine><addrLine>New Zealand</addrLine><country key="NZ" xml:lang="en">NEW ZEALAND</country></address></affiliation></author><author xml:id="author-0006"><persName><forename type="first">Allison L.</forename><surname>Miller</surname></persName><affiliation><orgName type="department">Department of Pathology</orgName><orgName type="department">Christchurch School of Medicine & Health Sciences</orgName><address><addrLine>Christchurch</addrLine><addrLine>New Zealand</addrLine><country key="NZ" xml:lang="en">NEW ZEALAND</country></address></affiliation></author><author xml:id="author-0007"><persName><forename type="first">Martin A.</forename><surname>Kennedy</surname></persName><affiliation><orgName type="department">Department of Pathology</orgName><orgName type="department">Christchurch School of Medicine & Health Sciences</orgName><address><addrLine>Christchurch</addrLine><addrLine>New Zealand</addrLine><country key="NZ" xml:lang="en">NEW ZEALAND</country></address></affiliation></author><idno type="istex">A4F78EDBF3F904AB205F89D64F4B27BA47774FE7</idno><idno type="ark">ark:/67375/WNG-L96SPX26-3</idno><idno type="DOI">10.1002/ajmg.b.30308</idno><idno type="unit">AJMG30308</idno><idno type="toTypesetVersion">file:AJMG.AJMG30308.pdf</idno></analytic><monogr><title level="j" type="main">American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</title><title level="j" type="alt">AMERICAN JOURNAL OF MEDICAL GENETICS PART B: NEUROPSYCHIATRIC GENETICS</title><idno type="pISSN">1552-4841</idno><idno type="eISSN">1552-485X</idno><idno type="book-DOI">10.1002/(ISSN)1552-485X</idno><idno type="book-part-DOI">10.1002/ajmg.b.v141b:4</idno><idno type="product">AJMG</idno><imprint><biblScope unit="vol">141B</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="409">409</biblScope><biblScope unit="page" to="413">413</biblScope><biblScope unit="page-count">5</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-06-05"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p>We have previously reported that the Ser9Gly dopamine D3 receptor (DRD3) polymorphism was associated with increased rates of obsessive‐compulsive personality disorder (OCPD) symptomology. We tested the replicability of this association within a further two independent groups of individuals with a history of depression, from a clinical sample (n = 149) and a family study (n = 213). The data from the replication samples and the original sample, within which the association was found, were compiled within a meta‐analysis. Although the independent samples did not replicate the original finding, the meta‐analysis elucidated significant evidence supporting the association. An individual with Gly/Gly genotype is 2.4 (<hi rend="italic">P</hi> = 0.017) times more likely to be diagnosed with OCPD. Male gender was also found to be a significant predictor of OCPD diagnosis (OR = 2.82, <hi rend="italic">P</hi> = 0.001). An exploration of an association of DRD3 with Axis I anxiety disorder diagnoses and Temperament and Character Inventory (TCI) traits, in particular persistence, revealed no support for an association. We conclude that DRD3 may contribute to the development of OCPD. © 2006 Wiley‐Liss, Inc.</p></abstract><textClass><keywords xml:lang="en"><term xml:id="kwd1">dopamine D3 receptor gene</term><term xml:id="kwd2">obsessive‐compulsive personality disorder</term></keywords><keywords rend="articleCategory"><term>Research Article</term></keywords><keywords rend="tocHeading1"><term>Research Articles</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-L96SPX26-3/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1552-485X</doi><issn type="print">1552-4841</issn><issn type="electronic">1552-485X</issn><idGroup><id type="product" value="AJMG"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="AMERICAN JOURNAL OF MEDICAL GENETICS PART B: NEUROPSYCHIATRIC GENETICS">American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</title><title type="short">Am. J. Med. Genet.</title></titleGroup><selfCitationGroup><citation type="ancestor" xml:id="cit1"><journalTitle>American Journal of Medical Genetics</journalTitle><accessionId ref="info:x-wiley/issn/01487299">0148-7299</accessionId><accessionId ref="info:x-wiley/issn/10968628">1096-8628</accessionId><pubYear year="2004">2004</pubYear></citation></selfCitationGroup></publicationMeta><publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/ajmg.b.v141b:4</doi><numberingGroup><numbering type="journalVolume" number="141">141B</numbering><numbering type="journalIssue">4</numbering></numberingGroup><coverDate startDate="2006-06-05">5 June 2006</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="150" status="forIssue"><doi origin="wiley" registered="yes">10.1002/ajmg.b.30308</doi><idGroup><id type="unit" value="AJMG30308"></id></idGroup><countGroup><count type="pageTotal" number="5"></count></countGroup><titleGroup><title type="articleCategory">Research Article</title><title type="tocHeading1">Research Articles</title></titleGroup><copyright ownership="publisher">Copyright © 2006 Wiley‐Liss, Inc.</copyright><eventGroup><event type="manuscriptReceived" date="2005-09-27"></event><event type="manuscriptAccepted" date="2006-01-05"></event><event type="publishedOnlineEarlyUnpaginated" date="2006-03-31"></event><event type="firstOnline" date="2006-03-31"></event><event type="publishedOnlineFinalForm" date="2006-05-19"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.6 mode:FullText source:FullText result:FullText" date="2010-05-07"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event></eventGroup><numberingGroup><numbering type="pageFirst">409</numbering><numbering type="pageLast">413</numbering></numberingGroup><correspondenceTo>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, PO Box 4345, Christchurch, New Zealand.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:AJMG.AJMG30308.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="2"></count><count type="referenceTotal" number="31"></count><count type="wordTotal" number="4657"></count></countGroup><titleGroup><title type="main" xml:lang="en">Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression<link href="#fn1"></link></title><title type="short" xml:lang="en">Dopamine D3 Receptor and Obsessive‐Compulsive Personality Disorder</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Katrina J.</givenNames><familyName>Light</familyName></personName><contactDetails><email>katrina.light@chmeds.ac.nz</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Peter R.</givenNames><familyName>Joyce</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Suzanne E.</givenNames><familyName>Luty</familyName></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Roger T.</givenNames><familyName>Mulder</familyName></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Christropher M.A.</givenNames><familyName>Frampton</familyName></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Laura R.M.</givenNames><familyName>Joyce</familyName></personName></creator><creator xml:id="au7" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Allison L.</givenNames><familyName>Miller</familyName></personName></creator><creator xml:id="au8" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Martin A.</givenNames><familyName>Kennedy</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="NZ" type="organization"><unparsedAffiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="NZ" type="organization"><unparsedAffiliation>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">dopamine D3 receptor gene</keyword><keyword xml:id="kwd2">obsessive‐compulsive personality disorder</keyword></keywordGroup><fundingInfo><fundingAgency>Health Research Council of New Zealand</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>We have previously reported that the Ser9Gly dopamine D3 receptor (DRD3) polymorphism was associated with increased rates of obsessive‐compulsive personality disorder (OCPD) symptomology. We tested the replicability of this association within a further two independent groups of individuals with a history of depression, from a clinical sample (n = 149) and a family study (n = 213). The data from the replication samples and the original sample, within which the association was found, were compiled within a meta‐analysis. Although the independent samples did not replicate the original finding, the meta‐analysis elucidated significant evidence supporting the association. An individual with Gly/Gly genotype is 2.4 (<i>P</i> = 0.017) times more likely to be diagnosed with OCPD. Male gender was also found to be a significant predictor of OCPD diagnosis (OR = 2.82, <i>P</i> = 0.001). An exploration of an association of DRD3 with Axis I anxiety disorder diagnoses and Temperament and Character Inventory (TCI) traits, in particular persistence, revealed no support for an association. We conclude that DRD3 may contribute to the development of OCPD. © 2006 Wiley‐Liss, Inc.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Please cite this article as follows: Light KJ, Joyce PR, Luty SE, Mulder RT, Frampton CMA, Joyce LRM, Miller AL, Kennedy MA. 2006. Preliminary Evidence for an Association Between a Dopamine D3 Receptor Gene Variant and Obsessive‐Compulsive Personality Disorder in Patients With Major Depression. Am J Med Genet Part B 141B:409–413.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Dopamine D3 Receptor and Obsessive‐Compulsive Personality Disorder</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression</title></titleInfo><name type="personal"><namePart type="given">Katrina J.</namePart><namePart type="family">Light</namePart><affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</affiliation><affiliation>E-mail: katrina.light@chmeds.ac.nz</affiliation><affiliation>Correspondence address: Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, PO Box 4345, Christchurch, New Zealand.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Peter R.</namePart><namePart type="family">Joyce</namePart><affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Suzanne E.</namePart><namePart type="family">Luty</namePart><affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Roger T.</namePart><namePart type="family">Mulder</namePart><affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Christropher M.A.</namePart><namePart type="family">Frampton</namePart><affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Laura R.M.</namePart><namePart type="family">Joyce</namePart><affiliation>Department of Psychological Medicine, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Allison L.</namePart><namePart type="family">Miller</namePart><affiliation>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Martin A.</namePart><namePart type="family">Kennedy</namePart><affiliation>Department of Pathology, Christchurch School of Medicine & Health Sciences, Christchurch, New Zealand</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2006-06-05</dateIssued><dateCaptured encoding="w3cdtf">2005-09-27</dateCaptured><dateValid encoding="w3cdtf">2006-01-05</dateValid><copyrightDate encoding="w3cdtf">2006</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">0</extent><extent unit="tables">2</extent><extent unit="references">31</extent><extent unit="words">4657</extent></physicalDescription><abstract lang="en">We have previously reported that the Ser9Gly dopamine D3 receptor (DRD3) polymorphism was associated with increased rates of obsessive‐compulsive personality disorder (OCPD) symptomology. We tested the replicability of this association within a further two independent groups of individuals with a history of depression, from a clinical sample (n = 149) and a family study (n = 213). The data from the replication samples and the original sample, within which the association was found, were compiled within a meta‐analysis. Although the independent samples did not replicate the original finding, the meta‐analysis elucidated significant evidence supporting the association. An individual with Gly/Gly genotype is 2.4 (P = 0.017) times more likely to be diagnosed with OCPD. Male gender was also found to be a significant predictor of OCPD diagnosis (OR = 2.82, P = 0.001). An exploration of an association of DRD3 with Axis I anxiety disorder diagnoses and Temperament and Character Inventory (TCI) traits, in particular persistence, revealed no support for an association. We conclude that DRD3 may contribute to the development of OCPD. © 2006 Wiley‐Liss, Inc.</abstract><note type="content">*Please cite this article as follows: Light KJ, Joyce PR, Luty SE, Mulder RT, Frampton CMA, Joyce LRM, Miller AL, Kennedy MA. 2006. Preliminary Evidence for an Association Between a Dopamine D3 Receptor Gene Variant and Obsessive‐Compulsive Personality Disorder in Patients With Major Depression. Am J Med Genet Part B 141B:409–413.</note><note type="funding">Health Research Council of New Zealand</note><subject lang="en"><genre>keywords</genre><topic>dopamine D3 receptor gene</topic><topic>obsessive‐compulsive personality disorder</topic></subject><relatedItem type="host"><titleInfo><title>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</title></titleInfo><titleInfo type="abbreviated"><title>Am. J. Med. Genet.</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Research Article</topic><topic>Research Articles</topic></subject><identifier type="ISSN">1552-4841</identifier><identifier type="eISSN">1552-485X</identifier><identifier type="DOI">10.1002/(ISSN)1552-485X</identifier><identifier type="PublisherID">AJMG</identifier><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>141B</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>409</start><end>413</end><total>5</total></extent></part></relatedItem><relatedItem type="preceding"><titleInfo><title>American Journal of Medical Genetics</title></titleInfo><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Accili</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CS</namePart><namePart type="family">Fishburn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Drago</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Steiner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JE</namePart><namePart type="family">Lachowicz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B‐H</namePart><namePart type="family">Park</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EB</namePart><namePart type="family">Gauda</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EJ</namePart><namePart type="family">Lee</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MH</namePart><namePart type="family">Cool</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DR</namePart><namePart type="family">Sibley</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park B‐H, Gauda EB, Lee EJ, Cool MH, Sibley DR, et al. 1996. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. PNAS 93: 1945–1949.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>1945</start><end>1949</end></extent></part><relatedItem type="host"><titleInfo><title>PNAS</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>1945</start><end>1949</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>Modulation of cocaine self‐administration in the rat through D‐3 dopamine receptors</title></titleInfo><name type="personal"><namePart type="given">SB</namePart><namePart type="family">Caine</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GF</namePart><namePart type="family">Koob</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Caine SB, Koob GF. 1993. Modulation of cocaine self‐administration in the rat through D‐3 dopamine receptors. Science 260: 1814–1816.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>260</number></detail><extent unit="pages"><start>1814</start><end>1816</end></extent></part><relatedItem type="host"><titleInfo><title>Science</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>260</number></detail><extent unit="pages"><start>1814</start><end>1816</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>A simple method for DNA purification from peripheral blood</title></titleInfo><name type="personal"><namePart type="given">TA</namePart><namePart type="family">Ciulla</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Sklar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SL</namePart><namePart type="family">Hauser</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ciulla TA, Sklar RM, Hauser SL. 1988. A simple method for DNA purification from peripheral blood. Anal Biochem 174: 485–488.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>174</number></detail><extent unit="pages"><start>485</start><end>488</end></extent></part><relatedItem type="host"><titleInfo><title>Anal Biochem</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>174</number></detail><extent unit="pages"><start>485</start><end>488</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>A psychobiological model of temperament and character</title></titleInfo><name type="personal"><namePart type="given">CR</namePart><namePart type="family">Cloninger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Svrakic</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TR</namePart><namePart type="family">Przybeck</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cloninger CR, Svrakic DM, Przybeck TR. 1993. A psychobiological model of temperament and character. Arch Gen Psychiatry 50: 975–990.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>975</start><end>990</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Gen Psychiatry</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>975</start><end>990</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>Dopamine recpetor D3 mRNA expression in human lyphocytes is negatively correlated with the personality trait of persistence</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Czermak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Lehofer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Renger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EM</namePart><namePart type="family">Wagner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Lemonis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Rohrhofer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Schauenstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PM</namePart><namePart type="family">Liebmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Czermak C, Lehofer M, Renger H, Wagner EM, Lemonis L, Rohrhofer A, Schauenstein K, Liebmann PM. 2004. Dopamine recpetor D3 mRNA expression in human lyphocytes is negatively correlated with the personality trait of persistence. J Neuroimmunol 150: 145–149.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>150</number></detail><extent unit="pages"><start>145</start><end>149</end></extent></part><relatedItem type="host"><titleInfo><title>J Neuroimmunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>150</number></detail><extent unit="pages"><start>145</start><end>149</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>Behavioural effects of the putative D‐3 dopamine receptor agonist 7‐OH‐DPAT in relation to other “D‐2‐like” agonists</title></titleInfo><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Daly</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Waddington</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Daly SA, Waddington JL. 1993. Behavioural effects of the putative D‐3 dopamine receptor agonist 7‐OH‐DPAT in relation to other “D‐2‐like” agonists. Neuropharmacology 32: 509–510.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>509</start><end>510</end></extent></part><relatedItem type="host"><titleInfo><title>Neuropharmacology</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>509</start><end>510</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders</title></titleInfo><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Henderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AE</namePart><namePart type="family">Korten</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AF</namePart><namePart type="family">Jorm</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Jacomb</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Christensen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Rodgers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Tan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Easteal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Henderson AS, Korten AE, Jorm AF, Jacomb PA, Christensen H, Rodgers B, Tan X, Easteal S. 2000. COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders. Am J Med Genet 96: 102–107.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>102</start><end>107</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Med Genet</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>96</number></detail><extent unit="pages"><start>102</start><end>107</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit9"><titleInfo><title>Association study between dopamine D3 receptor gene variant and personality traits</title></titleInfo><name type="personal"><namePart type="given">EG</namePart><namePart type="family">Jonsson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Burgert</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Crocq</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Gustavsson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Forslund</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Mattila‐Evenden</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Rylander</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LK</namePart><namePart type="family">Flyckt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Bjerkenstedt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FA</namePart><namePart type="family">Wiesel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jonsson EG, Burgert E, Crocq MA, Gustavsson JP, Forslund K, Mattila‐Evenden M, Rylander G, Flyckt LK, Bjerkenstedt L, Wiesel FA, et al. 2003. Association study between dopamine D3 receptor gene variant and personality traits. Am J Med Genet Part B Neuropsychiatr Genet 117B: 61–65.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>117B</number></detail><extent unit="pages"><start>61</start><end>65</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Med Genet Part B Neuropsychiatr Genet</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>117B</number></detail><extent unit="pages"><start>61</start><end>65</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit10"><titleInfo><title>Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline</title></titleInfo><name type="personal"><namePart type="given">PR</namePart><namePart type="family">Joyce</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RT</namePart><namePart type="family">Mulder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SE</namePart><namePart type="family">Luty</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PF</namePart><namePart type="family">Sullivan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">McKenzie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Abbott</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">IF</namePart><namePart type="family">Stevens</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM, Stevens IF. 2002. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust N Z J Psychiatry 36: 384–391.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>384</start><end>391</end></extent></part><relatedItem type="host"><titleInfo><title>Aust N Z J Psychiatry</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>384</start><end>391</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit11"><titleInfo><title>Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders</title></titleInfo><name type="personal"><namePart type="given">PR</namePart><namePart type="family">Joyce</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GR</namePart><namePart type="family">Rogers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AL</namePart><namePart type="family">Miller</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RT</namePart><namePart type="family">Mulder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SE</namePart><namePart type="family">Luty</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Kennedy</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Joyce PR, Rogers GR, Miller AL, Mulder RT, Luty SE, Kennedy MA. 2003. Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders. Psychiatry Res 119: 1–10.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>119</number></detail><extent unit="pages"><start>1</start><end>10</end></extent></part><relatedItem type="host"><titleInfo><title>Psychiatry Res</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>119</number></detail><extent unit="pages"><start>1</start><end>10</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit12"><titleInfo><title>Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self‐stimulation in the rat</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kling‐Petersen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Ljung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Wollter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Svensson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kling‐Petersen T, Ljung E, Wollter L, Svensson K. 1995. Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self‐stimulation in the rat. J Neural Transm Gen Sect 101: 27–39.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>101</number></detail><extent unit="pages"><start>27</start><end>39</end></extent></part><relatedItem type="host"><titleInfo><title>J Neural Transm Gen Sect</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>101</number></detail><extent unit="pages"><start>27</start><end>39</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit13"><titleInfo><title>Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Lannfelt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Sokoloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M‐P</namePart><namePart type="family">Martres</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Pilon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Giros</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Jonsson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Sedvall</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Schwartz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lannfelt L, Sokoloff P, Martres M‐P, Pilon C, Giros B, Jonsson E, Sedvall G, Schwartz JC. 1992. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 2: 249–256.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>249</start><end>256</end></extent></part><relatedItem type="host"><titleInfo><title>Psychiatr Genet</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>249</start><end>256</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit14"><titleInfo><title>D3 and D2 dopamine receptors: Visualization of cellular expression patterns in motor and limbic structures</title></titleInfo><name type="personal"><namePart type="given">ER</namePart><namePart type="family">Larson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Ariano</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Larson ER, Ariano MA. 1995. D3 and D2 dopamine receptors: Visualization of cellular expression patterns in motor and limbic structures. Synapse 20: 325–337.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>325</start><end>337</end></extent></part><relatedItem type="host"><titleInfo><title>Synapse</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>325</start><end>337</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit15"><titleInfo><title>Proposed schizophrenia‐related gene polymorphism: Expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Lundstrom</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MP</namePart><namePart type="family">Turpin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lundstrom K, Turpin MP. 1996. Proposed schizophrenia‐related gene polymorphism: Expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochem Biophys Res Commun 225: 1068–1072.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>225</number></detail><extent unit="pages"><start>1068</start><end>1072</end></extent></part><relatedItem type="host"><titleInfo><title>Biochem Biophys Res Commun</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>225</number></detail><extent unit="pages"><start>1068</start><end>1072</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit16"><titleInfo><title>D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion</title></titleInfo><name type="personal"><namePart type="given">LB</namePart><namePart type="family">Menalled</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Dziewczapolski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Garcia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Rubinstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">OS</namePart><namePart type="family">Gershanik</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Menalled LB, Dziewczapolski G, Garcia MC, Rubinstein M, Gershanik OS. 1999. D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion. Neuroreport 10: 3131–3136.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>3131</start><end>3136</end></extent></part><relatedItem type="host"><titleInfo><title>Neuroreport</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>3131</start><end>3136</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit17"><titleInfo><title>A new depression scale designed to be sensitive to change</title></titleInfo><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Montgomery</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Asberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382–389.</note><part><date>1979</date><detail type="volume"><caption>vol.</caption><number>134</number></detail><extent unit="pages"><start>382</start><end>389</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Psychiatry</title></titleInfo><part><date>1979</date><detail type="volume"><caption>vol.</caption><number>134</number></detail><extent unit="pages"><start>382</start><end>389</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit18"><titleInfo><title>Temperament and the structure of personality disorder symptoms</title></titleInfo><name type="personal"><namePart type="given">RT</namePart><namePart type="family">Mulder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PR</namePart><namePart type="family">Joyce</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mulder RT, Joyce PR. 1997. Temperament and the structure of personality disorder symptoms. Psychol Med 27: 99–106.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>99</start><end>106</end></extent></part><relatedItem type="host"><titleInfo><title>Psychol Med</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>99</start><end>106</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit19"><titleInfo><title>DSM‐III compulsive personality disorder: An epidemiological survey</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Nestadt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">Romanoski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CH</namePart><namePart type="family">Brown</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Chahal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Merchant</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MF</namePart><namePart type="family">Folstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EM</namePart><namePart type="family">Gruenberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PR</namePart><namePart type="family">McHugh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nestadt G, Romanoski AJ, Brown CH, Chahal R, Merchant A, Folstein MF, Gruenberg EM, McHugh PR. 1991. DSM‐III compulsive personality disorder: An epidemiological survey. Psychol Med 21: 461–471.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>461</start><end>471</end></extent></part><relatedItem type="host"><titleInfo><title>Psychol Med</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>461</start><end>471</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit20"><titleInfo><title>Obsessive‐compulsive behaviour: A disorder of decision making</title></titleInfo><name type="personal"><namePart type="given">PS</namePart><namePart type="family">Sachdev</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GS</namePart><namePart type="family">Malhi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sachdev PS, Malhi GS. 2005. Obsessive‐compulsive behaviour: A disorder of decision making. Aust N Z J Psychiatry 39: 767–773.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>767</start><end>773</end></extent></part><relatedItem type="host"><titleInfo><title>Aust N Z J Psychiatry</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>39</number></detail><extent unit="pages"><start>767</start><end>773</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit21"><titleInfo><title>Personality disorders and normal personality dimensions in obsessive‐compulsive disorder</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Samuels</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Nestadt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">OJ</namePart><namePart type="family">Bienvenu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PT</namePart><namePart type="family">Costa Jr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Riddle</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KY</namePart><namePart type="family">Liang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Hoehn‐Saric</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Grados</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BA</namePart><namePart type="family">Cullen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Samuels J, Nestadt G, Bienvenu OJ, Costa PT Jr, Riddle MA, Liang KY, Hoehn‐Saric R, Grados MA, Cullen BA. 2000. Personality disorders and normal personality dimensions in obsessive‐compulsive disorder. Br J Psychiatry 177: 457–462.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>177</number></detail><extent unit="pages"><start>457</start><end>462</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Psychiatry</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>177</number></detail><extent unit="pages"><start>457</start><end>462</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit22"><titleInfo><title>The Mini‐International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM‐IV and ICD‐10</title></titleInfo><name type="personal"><namePart type="given">DV</namePart><namePart type="family">Sheehan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Lecrubier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KH</namePart><namePart type="family">Sheehan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Amorim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Janavs</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Weiller</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Hergueta</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Baker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GC</namePart><namePart type="family">Dunbar</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini‐International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM‐IV and ICD‐10. J Clin Psychiatry 59: 22–33; quiz 34–57.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>22</start><end>33</end></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychiatry</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>59</number></detail><extent unit="pages"><start>22</start><end>33</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit23"><titleInfo><title>Molecular cloning and characterisation of a novel dopamine receptor (D3) as a target for neuroleptics</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Sokoloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Giros</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M‐P</namePart><namePart type="family">Martres</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M‐L</namePart><namePart type="family">Bouthenet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J‐C</namePart><namePart type="family">Schwartz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sokoloff P, Giros B, Martres M‐P, Bouthenet M‐L, Schwartz J‐C. 1990. Molecular cloning and characterisation of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146–150.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>347</number></detail><extent unit="pages"><start>146</start><end>150</end></extent></part><relatedItem type="host"><titleInfo><title>Nature</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>347</number></detail><extent unit="pages"><start>146</start><end>150</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit24"><titleInfo><title>Spitzer RL,Williams JBW,Gibbon M.1987.Structured Clinical Interview for DSM‐III‐R Personality Disorders.New York:Biometrics Research Department, New York State Psychiatric Institute.</title></titleInfo><note type="citation/reference">Spitzer RL, Williams JBW, Gibbon M. 1987. Structured Clinical Interview for DSM‐III‐R Personality Disorders. New York: Biometrics Research Department, New York State Psychiatric Institute.</note><name type="personal"><namePart type="given">RL</namePart><namePart type="family">Spitzer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JBW</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Gibbon</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Biometrics Research Department, New York State Psychiatric Institute</publisher><place><placeTerm type="text">New York</placeTerm></place></originInfo><part><date>1987</date></part><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit25"><titleInfo><title>The Structured Clinical Interview for DSM‐III‐R (SCID). I: History, rationale, and description</title></titleInfo><name type="personal"><namePart type="given">RL</namePart><namePart type="family">Spitzer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Gibbon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MB</namePart><namePart type="family">First</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Spitzer RL, Williams JB, Gibbon M, First MB. 1992. The Structured Clinical Interview for DSM‐III‐R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49: 624–629.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>624</start><end>629</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Gen Psychiatry</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><extent unit="pages"><start>624</start><end>629</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit26"><titleInfo><title>D3 dopamine receptor mRNA is widely expressed in the human brain</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Suzuki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">YL</namePart><namePart type="family">Hurd</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Sokoloff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Schwartz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Sedvall</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. 1998. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779: 58–74.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>779</number></detail><extent unit="pages"><start>58</start><end>74</end></extent></part><relatedItem type="host"><titleInfo><title>Brain Res</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>779</number></detail><extent unit="pages"><start>58</start><end>74</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit27"><titleInfo><title>Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Svensson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Carlsson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Huff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kling‐Petersen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Waters</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Svensson K, Carlsson A, Huff RM, Kling‐Petersen T, Waters N. 1994a. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol 263: 235–243.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>263</number></detail><extent unit="pages"><start>235</start><end>243</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Pharmacol</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>263</number></detail><extent unit="pages"><start>235</start><end>243</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit28"><titleInfo><title>Locomotor inhibition by the D3 ligand R‐(+)‐7‐OH‐DPAT is independent of changes in dopamine release</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Svensson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Carlsson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Waters</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Svensson K, Carlsson A, Waters N. 1994b. Locomotor inhibition by the D3 ligand R‐(+)‐7‐OH‐DPAT is independent of changes in dopamine release. J Neural Transm Gen Sect 95: 71–74.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>71</start><end>74</end></extent></part><relatedItem type="host"><titleInfo><title>J Neural Transm Gen Sect</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>95</number></detail><extent unit="pages"><start>71</start><end>74</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit29"><titleInfo><title>Obsessive‐compulsive personality disorder and behavioral disinhibition</title></titleInfo><name type="personal"><namePart type="given">NR</namePart><namePart type="family">Villemarette‐Pittman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MS</namePart><namePart type="family">Stanford</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KW</namePart><namePart type="family">Greve</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RJ</namePart><namePart type="family">Houston</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CW</namePart><namePart type="family">Mathias</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Villemarette‐Pittman NR, Stanford MS, Greve KW, Houston RJ, Mathias CW. 2004. Obsessive‐compulsive personality disorder and behavioral disinhibition. J Psychol 138: 5–22.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>138</number></detail><extent unit="pages"><start>5</start><end>22</end></extent></part><relatedItem type="host"><titleInfo><title>J Psychol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>138</number></detail><extent unit="pages"><start>5</start><end>22</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit30"><titleInfo><title>Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Waters</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Lofberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Haadsma‐Svensson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Svensson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Sonesson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Carlsson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Waters N, Lofberg L, Haadsma‐Svensson S, Svensson K, Sonesson C, Carlsson A. 1994. Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. J Neural Transm Gen Sect 98: 39–55.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>98</number></detail><extent unit="pages"><start>39</start><end>55</end></extent></part><relatedItem type="host"><titleInfo><title>J Neural Transm Gen Sect</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>98</number></detail><extent unit="pages"><start>39</start><end>55</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit31"><titleInfo><title>Polymorphisms in dopamine receptors: What do they tell us?</title></titleInfo><name type="personal"><namePart type="given">AH</namePart><namePart type="family">Wong</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CE</namePart><namePart type="family">Buckle</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HH</namePart><namePart type="family">Van Tol</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wong AH, Buckle CE, Van Tol HH. 2000. Polymorphisms in dopamine receptors: What do they tell us? Eur J Pharmacol 410: 183–203.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>410</number></detail><extent unit="pages"><start>183</start><end>203</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Pharmacol</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>410</number></detail><extent unit="pages"><start>183</start><end>203</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><relatedItem type="references" displayLabel="cit32"><titleInfo><title>Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Xu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TE</namePart><namePart type="family">Koeltzow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GT</namePart><namePart type="family">Santiago</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Moratalla</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DC</namePart><namePart type="family">Cooper</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">XT</namePart><namePart type="family">Hu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NM</namePart><namePart type="family">White</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Graybiel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FJ</namePart><namePart type="family">White</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Tonegawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM, Graybiel AM, White FJ, Tonegawa S. 1997. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19: 837–848.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>837</start><end>848</end></extent></part><relatedItem type="host"><titleInfo><title>Neuron</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>837</start><end>848</end></extent></part></relatedItem><identifier type="ISSN">0148-7299</identifier><identifier type="ISSN">1096-8628</identifier><part><date point="end">2004</date></part></relatedItem><identifier type="istex">A4F78EDBF3F904AB205F89D64F4B27BA47774FE7</identifier><identifier type="ark">ark:/67375/WNG-L96SPX26-3</identifier><identifier type="DOI">10.1002/ajmg.b.30308</identifier><identifier type="ArticleID">AJMG30308</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2006 Wiley‐Liss, Inc.</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-13</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-L96SPX26-3/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001154 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001154 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:A4F78EDBF3F904AB205F89D64F4B27BA47774FE7
|texte= Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive‐compulsive personality disorder in patients with major depression
}}
| This area was generated with Dilib version V0.6.33. |  |